- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05326750
Nieinwazyjna neurostymulacja jako narzędzie diagnostyki i postępowania w chorobach neurodegeneracyjnych
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Eino Solje, MD, PhD
- Numer telefonu: +358 17 713 311
- E-mail: eino.solje@uef.fi
Lokalizacje studiów
-
-
-
Kuopio, Finlandia
- Rekrutacyjny
- Kuopio University Hospital
-
Kontakt:
- Eino Solje
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Mild Cognitive Impairment due to Alzheimer's disease
- Dementia with Lewy Bodies
- Frontotemporal dementia
- Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion Criteria:
- History of seizures
- Pregnancy
- Metal implants in the head (except dental fillings)
- Electronic implants (i.e. pace-maker, implanted medical pump)
- Age <18 years
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Poczwórny
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Real tACS
Four sessions (once a day, during four consecutive days) of gamma tACS (40 Hz) at 3 mA over the superior parietal cortex (Precuneus) |
Single session of gamma tACS (40 Hz) over the superior parietal cortex |
|
Komparator placebo: Sham tACS
Four sessions of sham tACS (once a day, during four consecutive days) over the superior parietal cortex (Precuneus) |
Single session of gamma tACS (40 Hz) over the superior parietal cortex |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Changes in Rey Auditory Verbal Learning Test score
Ramy czasowe: Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. Another list of 15 unrelated words are given and the patient must again repeat the original list of 15 words and then again after 30 minutes. The examiner reads aloud 15 unrelated words and the participant is asked to recall the words after each of the five trials. After a 15 minute delay, the participant is asked again to recall the words. The score ranges from 0 (worst performance) to 75 (best performance). |
Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in Rey Auditory Verbal Learning Test, recognition
Ramy czasowe: Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. After a 15 minute delay, the participant is asked to recognise the original 15 words intermixed with 31 distractor words. The score of the recognition part ranges from 0 (worst performance) to 46 (best performance). |
Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in orientation to time and place (MMSE questions 1-10)
Ramy czasowe: Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
10 questions about the orientation. The score ranges from 0 (worse performance) to 10 (best performance). |
Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
|
Changes in Trail Making A & B tests
Ramy czasowe: Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
TMT A & B tests. Time to perform set is recorded. |
Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in INECO Frontal Screening test
Ramy czasowe: Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
Test battery assessing frontal lobe functions. The score ranges from 0 (worse performance) to 30 (best performance) |
Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in phonemic fluency
Ramy czasowe: Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Person is requested to provide as many words as possible starting with certain letter. The score is the sum of all acceptable words produced in one minute. |
Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Change in SAI measurements
Ramy czasowe: Baseline (immediately before the intervention), immediately after the last intervention
|
By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on short latency afferent inhibition (SAI), which is a marker of cholinergic neurotransmission. |
Baseline (immediately before the intervention), immediately after the last intervention
|
|
Change in SICI measurements
Ramy czasowe: Baseline (immediately before the intervention), immediately after the last intervention
|
By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on short interval intracortical inhibition (SICI), which is a marker of gabaergic neurotransmission. |
Baseline (immediately before the intervention), immediately after the last intervention
|
|
Change in ICF measurements
Ramy czasowe: Baseline (immediately before the intervention), immediately after the last intervention
|
By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on intracortical facilitation (ICF), which is a marker of glutamatergic neurotransmission. |
Baseline (immediately before the intervention), immediately after the last intervention
|
|
Change in modified Frontal Behavioral Inventory (FBI-mod) score
Ramy czasowe: Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
The modified Frontal Behavioral Inventory (FBI-mod) is used to assess behavioral symptoms associated with frontotemporal dysfunction. The questionnaire evaluates changes in behavioral and personality features. Higher scores indicate a greater severity of behavioral symptoms. |
Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
|
Change in Neuropsychiatric Inventory (NPI) score
Ramy czasowe: Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
The Neuropsychiatric Inventory (NPI) is used to assess neuropsychiatric symptoms, including their frequency and severity. Higher total scores indicate a greater burden of neuropsychiatric symptoms. |
Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Eino Solje, MD, PhD, Kuopio University Hospital
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Synukleinopatie
- Choroby mózgu
- Choroby ośrodkowego układu nerwowego
- Choroby Układu Nerwowego
- Zaburzenia psychiczne
- Choroby metaboliczne
- Zaburzenia neurokognitywne
- Demencja
- Tauopatie
- Choroby neurodegeneracyjne
- Zaburzenia ruchowe
- Zaburzenia Parkinsona
- Choroby jąder podstawy
- TDP-43 Proteinopatie
- Niedobory proteostazy
- Zwyrodnienie płata czołowo-skroniowego
- Choroby żywieniowe i metaboliczne
- Choroba Alzheimera
- Otępienie czołowo-skroniowe
- Choroba ciał Lewy'ego
Inne numery identyfikacyjne badania
- KUH5772859
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Pseudonymized data upon request, according to Finnish national and EU GDPR regulations
Ramy czasowe udostępniania IPD
Data will be shared after the study completion indefinitely.
Kryteria dostępu do udostępniania IPD
Reasonable request
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .